Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease

• Status: Completed
• Trial end date: 2005-08-01
• Target enrollment: 0
• Participant gender: All

Summary

one year extension study following a previous double-blind study to evaluate safety of the drug

• Phase: Phase 3

Details

• Lead Sponsor: University Health Network, Toronto
• Collaborator: Eisai Inc.
• Treatments: Donepezil

Criteria

Inclusion Criteria:

• must have completed previous study E2020-A001-319

Exclusion Criteria:

• absence of a reliable caregiver

• clinically significant medical condition

• recent TIA